Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Thomas Comfort

Orthopaedic Surgery Oak Park Heights, MN Medical Doctor

NPI 1669443495 CMS profile 410569

5803 Neal Ave N, Oak Park Heights, MN 55082

Open in the dashboard

General payments

$4,411

25 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Thomas Comfort of Oak Park Heights, MN is reported in the CMS Open Payments database as having received $4,411 across 25 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 54th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $105 4
2024 General $790 5
2023 General $48 2
2022 General $1,244 4
2020 General $2,224 10

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Thomas Comfort
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Thomas Comfort were reported at $105. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Thomas Comfort Orthopaedic Surgery median Middle half National median
2019 $0 $644 $140–$2,844 $163
2020 $2,224 $312 $75–$1,860 $114
2021 $0 $520 $117–$2,495 $132
2022 $1,244 $598 $128–$2,731 $149
2023 $48 $461 $128–$2,264 $160
2024 $790 $497 $134–$2,475 $164
2025 $105 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Arthrex, Inc. $3,351 13 payments
  2. Stryker Corporation $996 10 payments
  3. Smith+Nephew, Inc. $38 1 payment
  4. Foundation Medical, LLC $25 1 payment

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Education $3,217 3 payments
  2. Travel and Lodging $776 6 payments
  3. Food and Beverage $417 16 payments
Products named General payments · program years 2020–2025
  1. MAKO Knees, Hips $634 6 payments
  2. ACCOLADE $215 1 payment
  3. MAKO Knees, Hips $116 1 payment
  4. N/A $38 1 payment
  5. EVOS $38 1 payment
  6. LENS 4K $38 1 payment
  7. NA $38 1 payment
  8. MAKO Joint Replacement Hips, Knees $17 1 payment
  9. TRIATHLON $14 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

477

Median for Orthopedic Surgery: 203

Drug cost

$2,294

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Methocarbamol Generic 105 $844
Oxycodone Hcl Generic 126 $796
Amoxicillin Generic 128 $243
Meloxicam Generic 55 $198
Methylprednisolone Generic 16 $117
Tramadol Hcl Generic 25 $70
Clindamycin Hcl Generic 22 $25

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 56 billing codes

Paid by Medicare

$104,436

Of which drugs: $2,767

Medicare patients

241

Average age 73

Services billed

2,136

161 women, 80 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 68%
Ischemic heart disease 30%
Depression 30%
Chronic kidney disease 29%
Diabetes 20%
Osteoporosis 19%
Atrial fibrillation 18%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose J7323 Office 11 18 $1,698
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 100 1,137 $822
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml Q9966 Office 19 70 $19

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

25 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Minnesota

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record